A detailed history of Financial Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Financial Advisors, LLC holds 4,096 shares of ABT stock, worth $478,412. This represents 0.09% of its overall portfolio holdings.

Number of Shares
4,096
Previous 4,096 -0.0%
Holding current value
$478,412
Previous $425,000 9.65%
% of portfolio
0.09%
Previous 0.09%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$90.19 - $110.4 $18,038 - $22,080
-200 Reduced 4.66%
4,096 $450,000
Q3 2023

Oct 10, 2023

SELL
$95.53 - $114.62 $19,106 - $22,924
-200 Reduced 4.45%
4,296 $416,000
Q2 2023

Aug 01, 2023

SELL
$100.78 - $112.29 $3,023 - $3,368
-30 Reduced 0.66%
4,496 $490,000
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $24,525 - $28,772
-258 Reduced 5.39%
4,526 $497,000
Q4 2021

Feb 11, 2022

SELL
$115.53 - $141.46 $4,852 - $5,941
-42 Reduced 0.87%
4,784 $673,000
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $16,099 - $17,810
138 Added 2.94%
4,826 $570,000
Q1 2021

Apr 16, 2021

BUY
$108.84 - $128.23 $3,265 - $3,846
30 Added 0.64%
4,688 $562,000
Q4 2020

Feb 12, 2021

SELL
$105.0 - $114.42 $28,875 - $31,465
-275 Reduced 5.57%
4,658 $510,000
Q3 2020

Nov 13, 2020

BUY
$91.64 - $111.29 $13,746 - $16,693
150 Added 3.14%
4,933 $537,000
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $20,542 - $30,038
-327 Reduced 6.4%
4,783 $377,000
Q4 2019

Feb 13, 2020

BUY
$78.51 - $87.4 $10,912 - $12,148
139 Added 2.8%
5,110 $444,000
Q3 2019

Nov 05, 2019

BUY
$81.84 - $88.74 $20,460 - $22,185
250 Added 5.3%
4,971 $416,000
Q2 2019

Jul 31, 2019

BUY
$72.88 - $85.0 $3,644 - $4,250
50 Added 1.07%
4,721 $397,000
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $306,230 - $346,915
4,671 New
4,671 $338,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Financial Advisors, LLC Portfolio

Follow Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial Advisors, LLC with notifications on news.